Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Oct 28, 2020

Mark Campbell, Vice President, Clinical Solutions RxBenefits on their technology-enabled prescription benefits services being offered to self-funded employer groups who are managing their own benefits. COVID-19 has driven changes in enrollment and demand for services as well changing the number of prescriptions and...


Oct 28, 2020

Mark Campbell, Vice President, Clinical Solutions RxBenefits on their technology-enabled prescription benefits services being offered to self-funded employer groups who are managing their own benefits. COVID-19 has driven changes in enrollment and demand for services as well changing the number of prescriptions and...


Oct 27, 2020

Dr. Nishi Rawat, Senior Vice President, Appriss Health and Co-Founder OpenBeds shines a light on the challenges of finding appropriate substance abuse disorder and mental health treatment especially in light of the additional challenges from COVID-19. Instead of a clinician facing network, development of a consumer...


Oct 27, 2020

Dr. Nishi Rawat, Senior Vice President, Appriss Health and Co-Founder OpenBeds shines a light on the challenges of finding appropriate substance abuse disorder and mental health treatment especially in light of the additional challenges from COVID-19. Instead of a clinician facing network, development of a consumer...


Oct 26, 2020

Rahul Aras, CEO, Iterion Therapeutics, describes their lead product Tegavivint, a potent selective inhibitor of nuclear beta-catenin, a high-value oncology target because of its role in cell proliferation, differentiation, immune evasion and other aspects of cancer development. An early clinical study in patients with...